Brigitha, Leiah J. http://orcid.org/0000-0003-2816-2610
Mondelaers, Veerle
Liu, Yiwei
Albertsen, Birgitte K.
Zalewska-Szewczyk, Beata
Rizzari, Carmelo
Kotecha, Rishi S.
Pieters, Rob
Huitema, Alwin D. R.
van der Sluis, Inge M.
Funding for this research was provided by:
Belgian Federal Public Service of Health (Cancer Plan Action 29)
Vlaamse Liga Tegen Kanker
Article History
Received: 10 November 2023
Accepted: 14 March 2024
First Online: 27 March 2024
Declarations
:
: LJB: Speaker fee from Servier and Clinigen.VM: Participation in advisory boards of Servier and Clinigen, and travel grants from Servier and Jazz Pharmaceuticals.BKA: Participation in advisory boards of Jazz Pharmaceuticals.RP: Participation in advisory boards of Servier, Jazz Pharmaceuticals and Clinigen. And speaker fee from Servier and Clinigen.IvdS: Participation in advisory boards of Servier, Jazz Pharmaceuticals and Clinigen. And speaker fee from Servier and Clinigen.